173 related articles for article (PubMed ID: 28566935)
1. Variations in Echogenicity in Carotid and Femoral Atherosclerotic Plaques with Pycnogenol + Centella Asiatica Supplementation.
Belcaro G; Cornelli U
Int J Angiol; 2017 Jun; 26(2):95-101. PubMed ID: 28566935
[TBL] [Abstract][Full Text] [Related]
2. Carotid plaque stabilization induced by the supplement association Pycnogenol® and centella asiatica (Centellicum®).
Luzzi R; Belcaro G; Ippolito E
Minerva Cardioangiol; 2016 Dec; 64(6):603-9. PubMed ID: 26496510
[TBL] [Abstract][Full Text] [Related]
3. Pycnogenol® and Centella asiatica to prevent asymptomatic atherosclerosis progression in clinical events.
Belcaro G; Dugall M; Ippolito E; Hosoi M; Cornelli U; Ledda A; Scoccianti M; Cesarone MR; Pellegrini L; Luzzi R; Corsi M; Feragalli B
Minerva Cardioangiol; 2017 Feb; 65(1):24-31. PubMed ID: 26505327
[TBL] [Abstract][Full Text] [Related]
4. Pycnogenol® and Centella asiatica in the management of asymptomatic atherosclerosis progression.
Belcaro G; Ippolito E; Dugall M; Hosoi M; Cornelli U; Ledda A; Scoccianti M; Steigerwalt RD; Cesarone MR; Pellegrini L; Luzzi R; Corsi M
Int Angiol; 2015 Apr; 34(2):150-7. PubMed ID: 25519846
[TBL] [Abstract][Full Text] [Related]
5. Central cardiovascular calcifications: supplementation with Pycnogenol® and Centellicum®: variations over 12 months.
Hu S; Belcaro G; Cesarone MR; Feragalli B; Cotellese R; Dugall M; Scipione C; Scipione V; Maione C
Minerva Cardioangiol; 2020 Feb; 68(1):22-26. PubMed ID: 31633315
[TBL] [Abstract][Full Text] [Related]
6. Delayed progression of atherosclerosis and cardiovascular events in asymptomatic patients with atherosclerotic plaques: 3-year prevention with the supplementation with Pycnogenol®+Centellicum®.
Belcaro G; Cesarone MR; Scipione C; Scipione V; Dugall M; Shu H; Peterzan P; Corsi M; Luzzi R; Hosoi M; Feragalli B; Cotellese R
Minerva Cardioangiol; 2020 Feb; 68(1):15-21. PubMed ID: 31625707
[TBL] [Abstract][Full Text] [Related]
7. Keloidal penile fibrosis: improvements with Centellicum® (Centella asiatica) and Pycnogenol® supplementation: a pilot registry.
Ledda A; Cornelli U; Belcaro G; Dugall M; Feragalli B; Cotellese R; Hu S; Corsi M
Panminerva Med; 2020 Mar; 62(1):13-18. PubMed ID: 32199407
[TBL] [Abstract][Full Text] [Related]
8. Pycnogenol® and Centella Asiatica for asymptomatic atherosclerosis progression.
Belcaro G; Dugall M; Hosoi M; Ippolito E; Cesarone M; Luzzi R; Cornelli U; Ledda A
Int Angiol; 2014 Feb; 33(1):20-6. PubMed ID: 24452082
[TBL] [Abstract][Full Text] [Related]
9. Pycnogenol®+Centellicum®, post-stent evaluation: prevention of neointima and plaque re-growth.
Belcaro G; Cesarone MR; Scipione C; Scipione V; Dugall M; Hu S; Feragalli B; Luzzi R; Hosoi M; Maione C; Cotellese R
Minerva Cardioangiol; 2019 Dec; 67(6):450-455. PubMed ID: 31850725
[TBL] [Abstract][Full Text] [Related]
10. Pycnogenol®-Centellicum® supplementation improves lung fibrosis and post-COVID-19 lung healing.
Cesarone MR; Hu S; Belcaro G; Cornelli U; Feragalli B; Corsi M; Bombardelli E; Cotellese R; Hosoi M; Rosenkvist L
Minerva Med; 2022 Feb; 113(1):135-140. PubMed ID: 34180638
[TBL] [Abstract][Full Text] [Related]
11. Postpartum stretchmarks: repairing activity of an oral Centella asiatica supplementation (Centellicum®).
Hu S; Belcaro G; Hosoi M; Feragalli B; Luzzi R; Dugall M
Minerva Ginecol; 2018 Oct; 70(5):629-634. PubMed ID: 30293400
[TBL] [Abstract][Full Text] [Related]
12. Increase in echogenicity of echolucent carotid plaques after treatment with total triterpenic fraction of Centella asiatica: a prospective, placebo-controlled, randomized trial.
Cesarone MR; Belcaro G; Nicolaides AN; Geroulakos G; Bucci M; Dugall M; De Sanctis MT; Incandela L; Griffin M; Sabetai M
Angiology; 2001 Oct; 52 Suppl 2():S19-25. PubMed ID: 11666118
[TBL] [Abstract][Full Text] [Related]
13. Modification of the echogenicity of femoral plaques after treatment with total triterpenic fraction of Centella asiatica: a prospective, randomized, placebo-controlled trial.
Incandela L; Belcaro G; Nicolaides AN; Cesarone MR; De Sanctis MT; Corsi M; Bavera P; Ippolito E; Griffin M; Geroulakos G; Sabetai M; Ramaswami G; Veller M
Angiology; 2001 Oct; 52 Suppl 2():S69-73. PubMed ID: 11666127
[TBL] [Abstract][Full Text] [Related]
14. The COFU3 Study. Improvement in cognitive function, attention, mental performance with Pycnogenol® in healthy subjects (55-70) with high oxidative stress.
Belcaro G; Dugall M; Ippolito E; Hu S; Saggino A; Feragalli B
J Neurosurg Sci; 2015 Dec; 59(4):437-46. PubMed ID: 26635191
[TBL] [Abstract][Full Text] [Related]
15. Episodic primary migraine headache: supplementary prophylaxis with Pycnogenol® prevents attacks and controls oxidative stress.
Cesarone MR; Dugall M; Hu S; Belcaro G; Hosoi M; Scipione V; Scipione C; Cotellese R
Panminerva Med; 2020 Jun; 62(2):102-108. PubMed ID: 31670494
[TBL] [Abstract][Full Text] [Related]
16. Periostial and cartilage morphology in knee osteoarthritis: beneficial effects of supplementation with Pycnogenol® + Centellicum®.
Belcaro G; Cesarone MR; Scipione C; Scipione V; Hosoi M; Hu S; Ledda A; Feragalli B; Cotellese R; Cox D
Minerva Surg; 2024 Feb; 79(1):40-47. PubMed ID: 38381030
[TBL] [Abstract][Full Text] [Related]
17. Preventive effects of Pycnogenol® on cardiovascular risk factors (including endothelial function) and microcirculation in subjects recovering from coronavirus disease 2019 (COVID-19).
Belcaro G; Cornelli U; Cesarone MR; Scipione C; Scipione V; Hu S; Feragalli B; Corsi M; Cox D; Cotellese R; Hosoi M; Burki C
Minerva Med; 2022 Apr; 113(2):300-308. PubMed ID: 34060731
[TBL] [Abstract][Full Text] [Related]
18. Pycnogenol® supplementation alleviates symptoms of Parkinson's disease with mild cognitive impairment.
Belcaro G; Cesarone MR; Hu S; Hosoi M; Ledda A; Feragalli B; Saggino A; Cotellese R
J Neurosurg Sci; 2022 Aug; 66(4):371-377. PubMed ID: 36153882
[TBL] [Abstract][Full Text] [Related]
19. Pycnogenol® improves cognitive function, attention, mental performance and specific professional skills in healthy professionals aged 35-55.
Belcaro G; Luzzi R; Dugall M; Ippolito E; Saggino A
J Neurosurg Sci; 2014 Dec; 58(4):239-48. PubMed ID: 24675223
[TBL] [Abstract][Full Text] [Related]
20. Management of mild, primary Raynaud Syndrome: supplementation with Pycnogenol®.
Hu S; Hosoi M; Belcaro G; Dugall M; Feragalli B; Cotellese R; Luzzi R
Minerva Cardioangiol; 2019 Oct; 67(5):392-398. PubMed ID: 31637898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
